CYCLOSPORIN AND TACROLIMUS USEFULNESS IN VERNAL CONJUNCTIVITIS

This report in Current Allergy and Asthma Reports discusses the use and effectiveness of cyclosporin and tacrolimus for the treatment of vernal conjunctivitis.

Topical corticosteroids, often required for controlling symptoms and signs in severe VKC, can lead to serious ocular complications. Immunomodulators that have been investigated for VKC treatment include topical ocular preparations of cyclosporine A and tacrolimus. Severe VKC responds promptly to topical cyclosporine A and tacrolimus, mostly within 1 month of therapy. Prolonged use of cyclosporine A and tacrolimus in VKC is safe and is tolerated by most patients without significant side effects.